We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expedited Drug Reviews Raise Safety Concerns, Industry Experts Warn
Expedited Drug Reviews Raise Safety Concerns, Industry Experts Warn
November 1, 2013
Because fewer patients are studied as part of the expedited drug approval process, many such drugs hit the market with significant safety questions unanswered, a study released Oct. 28 says.